STRATTERA Safety Questions, STRATTERA Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about STRATTERA. Our extensive database of STRATTERA adverse events and STRATTERA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about STRATTERA

STRATTERA Safety Reports

Total STRATTERA reports: 657.
STRATTERA FDA safety alerts: 2004 2005 .
Reported deaths: 39 Reported hospitalizations: 181.
Take STRATTERA Side Effects Survey or Share Your STRATTERA Story. STRATTERA Usage.

Showing 1-75 of 657 Next >

Physician from UNITED STATES reported STRATTERA problem on Feb 07, 2007. Male patient, 14 years of age, weighting 119.5 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: chest pain, dizziness, loss of consciousness, tachycardia. STRATTERA dosage: 60 MG, UNK. During the same period patient was treated with WELLBUTRIN. Patient recovered.

STRATTERA problem was reported by a Physician from PUERTO RICO on Jan 30, 2007. Male patient, child 9 years of age, weighting 74.99 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: completed suicide. STRATTERA dosage: 18 MG, UNK. Patient died on 12/01/2005.

Pharmacist from UNITED STATES reported STRATTERA problem on Feb 16, 2007. Female patient, 14 years of age, weighting 117.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depressed level of consciousness, family stress, incorrect dose administered, sleep disorder, suicide attempt. STRATTERA dosage: 80MG DAILY PO. During the same period patient was treated with SEASONALE. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Feb 09, 2007. Male patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: optic nerve disorder, optic neuritis, sinusitis, skin papilloma. STRATTERA dosage: 80 MG, DAILY (1/D). Patient recovered.

Physician from CANADA reported STRATTERA problem on Feb 09, 2007. Male patient, 17 years of age, weighting 141.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, fatigue, high density lipoprotein decreased, malaise. STRATTERA dosage: 40 MG, DAILY (1/D). During the same period patient was treated with ACCUTANE. Patient recovered.

STRATTERA problem was reported by a Physician from GERMANY on Feb 08, 2007. Male patient, 25 years of age, weighting 165.3 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt. STRATTERA dosage: 960 MG, UNK. During the same period patient was treated with PIPAMPERONE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported STRATTERA problem on Feb 08, 2007. Female patient, 17 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: amenorrhoea. STRATTERA dosage: 60 MG, DAILY (1/D). Patient recovered.

STRATTERA problem was reported by a Physician from BELGIUM on Feb 09, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: convulsion, syncope. STRATTERA dosage: unknown. Patient recovered.

Physician from UNITED KINGDOM reported STRATTERA problem on Feb 08, 2007. Male patient, child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, jaundice. STRATTERA dosage: unknown. Patient recovered.

STRATTERA problem was reported by a Pharmacist from UNITED STATES on Feb 20, 2007. Male patient, weighting 80.25 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: suicidal ideation, suicide attempt. STRATTERA dosage: 25 MG ONCE DAILY PO. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported STRATTERA problem on Feb 14, 2007. Male patient, 14 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. STRATTERA dosage: unknown. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Health Professional from UNITED STATES on Feb 26, 2007. Male patient, weighting 50.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: agitation, dysuria, feelings of worthlessness, hallucination, auditory. STRATTERA dosage: 18 MG TWICE DAILY PO. Patient recovered.

Physician from GERMANY reported STRATTERA problem on Feb 15, 2007. Male patient, 14 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: collapse of lung. STRATTERA dosage: 18 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from GERMANY on Feb 15, 2007. Male patient, 15 years of age, weighting 164.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: angiopathy, fall, myelitis, paresis, urinary retention. STRATTERA dosage: 60 MG, DAILY (1/D). Patient was hospitalized and became disabled. Patient recovered.

Physician from CHILE reported STRATTERA problem on Feb 15, 2007. Male patient, 17 years of age, was diagnosed with attention deficit/hyperactivity disorder, personality disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, intentional overdose, suicide attempt. STRATTERA dosage: 800 MG, DAILY (1/D). During the same period patient was treated with VALPROIC ACID, VALPROIC ACID, SPIRON, SOCIAN, RAVOTRIL, PAROXETINE. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2006. Male patient, 14 years of age, weighting 349.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: weight decreased, weight increased. STRATTERA dosage: 80 MG. During the same period patient was treated with PROZAC, CLONIDINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STRATTERA problem on Aug 15, 2006. Female patient, 53 years of age, was diagnosed with attention deficit/hyperactivity disorder, depression and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, dyslexia, feeling abnormal, nerve injury, panic attack, psychomotor hyperactivity. STRATTERA dosage: 80 MG. During the same period patient was treated with PROZAC, OXYCODONE, KLONOPIN, TRIAMTERENE, ALBUTEROL, AZAMACORT, POTASSIUM, FIORINAL. Patient recovered.

STRATTERA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, 55 years of age, was diagnosed with depression and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, endometrial hyperplasia, hypertension, nausea, overweight, psychiatric symptom, tinnitus. STRATTERA dosage: 50 MG. During the same period patient was treated with CYMBALTA, PROVIGIL, KLONOPIN, FLUOXETINE. Patient recovered.

Physician from CANADA reported STRATTERA problem on Feb 16, 2007. Female patient, child 8 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: tuberculosis. STRATTERA dosage: unknown. Patient recovered.

STRATTERA problem was reported by a Physician from BELGIUM on Feb 21, 2007. Female patient, child 7 years of age, weighting 54.90 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, affect lability, aggression, agitation, depressed mood, enuresis, negativism, suicidal ideation. STRATTERA dosage: 29 MG, DAILY (1/D). During the same period patient was treated with RILATINE. Patient recovered.

Physician from AUSTRIA reported STRATTERA problem on Feb 21, 2007. Female patient, 16 years of age, weighting 161.6 lb, was diagnosed with attention deficit/hyperactivity disorder, aggression and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: impulse-control disorder, restlessness, sleep disorder. STRATTERA dosage: 72 MG, DAILY (1/D). During the same period patient was treated with TRUXAL. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from CANADA on Feb 20, 2007. Male patient was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: conduct disorder, fatigue. STRATTERA dosage: 60 MG, UNK. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Feb 20, 2007. Male patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: suicide attempt. STRATTERA dosage: 80 MG, UNK. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Female patient, child 8 years of age, weighting 53.35 lb, was diagnosed with pain, enterobiasis and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: cholestasis, chromaturia, enterobiasis, hepatitis, hypertension, nausea, prothrombin time prolonged, pruritus, rash. STRATTERA dosage: 25 MG, UNK. During the same period patient was treated with MEBENDAZOLE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Feb 22, 2007. Male patient, 14 years of age, weighting 138.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bone marrow failure, fatigue, hepatitis, neutropenia, thrombocytopenia. STRATTERA dosage: 80 MG, DAILY (1/D). During the same period patient was treated with ZOLOFT. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Feb 22, 2007. Female patient, 31 years of age, weighting 146.3 lb, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, hepatitis cholestatic, hepatitis viral, jaundice, liver disorder, nausea. STRATTERA dosage: 40 MG, DAILY (1/D). During the same period patient was treated with WELLBUTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STRATTERA problem on Mar 07, 2007. Male patient, 25 years of age, weighting 155.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. STRATTERA dosage: unknown. Patient recovered.

STRATTERA problem was reported by a Physician from AUSTRALIA on Feb 23, 2007. Male patient, child 7 years of age, weighting 57.32 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. STRATTERA dosage: 10 MG, DAILY (1/D). Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Feb 26, 2007. Male patient, child 5 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: hydronephrosis. STRATTERA dosage: unknown. During the same period patient was treated with RISPERDAL. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Feb 26, 2007. Male patient, 21 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: convulsion, loss of consciousness. STRATTERA dosage: unknown. During the same period patient was treated with AMNESTEEM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STRATTERA problem on Feb 26, 2007. Male patient, child 7 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: dehydration, dysarthria, fatigue, headache, heart rate increased, lethargy, neck pain, oral discharge. STRATTERA dosage: 18 MG, DAILY (1/D). During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from GERMANY on Feb 26, 2007. Male patient, 28 years of age, weighting 191.8 lb, was diagnosed with attention deficit/hyperactivity disorder, diabetes mellitus insulin-dependent and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. STRATTERA dosage: 60 MG, DAILY (1/D). During the same period patient was treated with HUMALOG, EFEROX. Patient recovered.

Physician from UNITED KINGDOM reported STRATTERA problem on Feb 27, 2007. Male patient, child 5 years of age, weighting 50.16 lb, was diagnosed with attention deficit/hyperactivity disorder, ear infection, chest discomfort and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anxiety, blood pressure increased, fear, hallucination. STRATTERA dosage: 10 MG, UNK. During the same period patient was treated with AMOXICILLIN, BECOTIDE, FISH OIL, VENTOLIN. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Male patient, 15 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: jaundice, liver function test abnormal. STRATTERA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Feb 28, 2007. Male patient, 19 years of age, weighting 154.3 lb, was diagnosed with attention deficit/hyperactivity disorder, sedation and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, cardiac murmur, depressed level of consciousness, electrocardiogram qt prolonged, hallucination, auditory, hallucination, visual, intentional overdose. STRATTERA dosage: 1200 MG, OTHER. During the same period patient was treated with OLANZAPINE, OXCARBAZEPINE, QUETIAPINE FUMARATE, PAROXETINE, ALBUTEROL, MONTELUKAST, ATIVAN. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from CANADA on Mar 01, 2007. Male patient was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: educational problem, fatigue, impulsive behaviour. STRATTERA dosage: 60 MG, UNK. Patient recovered.

Physician from UNITED KINGDOM reported STRATTERA problem on Mar 02, 2007. Male patient, child 10 years of age, weighting 68.34 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: confusional state, cyanosis, depression, feeling abnormal, feeling cold, loss of consciousness, malaise, nasopharyngitis, pallor. STRATTERA dosage: 40 MG, DAILY (1/D). Patient recovered.

STRATTERA problem was reported by a Physician from UNITED KINGDOM on Mar 05, 2007. Female patient, 15 years of age, weighting 83.99 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: intentional overdose, mydriasis, tachycardia. STRATTERA dosage: 50 MG, DAILY (1/D). During the same period patient was treated with RITALIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 05, 2007. Male patient, 16 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: skin discolouration. STRATTERA dosage: 80 MG, DAILY (1/D). Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Mar 05, 2007. Female patient, 14 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, skin discolouration. STRATTERA dosage: 80 MG, DAILY (1/D). Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 05, 2007. Male patient, 15 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: peripheral coldness, skin discolouration. STRATTERA dosage: 80 MG, DAILY (1/D). Patient recovered.

STRATTERA problem was reported by a Physician from CANADA on Mar 07, 2007. Male patient, 17 years of age, weighting 141.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, fatigue, high density lipoprotein decreased, malaise. STRATTERA dosage: 40 MG, DAILY (1/D). Patient recovered.

Physician from GERMANY reported STRATTERA problem on Mar 06, 2007. Male patient, 28 years of age, weighting 191.8 lb, was diagnosed with attention deficit/hyperactivity disorder, diabetes mellitus insulin-dependent and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, vomiting. STRATTERA dosage: 40 MG, DAILY (1/D). During the same period patient was treated with HUMALOG, EFEROX. Patient recovered.

STRATTERA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Male patient, 19 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, blood lactate dehydrogenase increased, cough, sputum abnormal. STRATTERA dosage: 80 MG, UNK. Patient recovered.

Physician from PUERTO RICO reported STRATTERA problem on Mar 09, 2007. Male patient, child 9 years of age, weighting 74.99 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: completed suicide, injury asphyxiation. STRATTERA dosage: 18 MG, UNK. Patient died on 12/05/2005.

STRATTERA problem was reported by a Physician from UNITED STATES on Mar 07, 2007. Female patient was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: ileus, oedema. STRATTERA dosage: 100 MG, UNK. During the same period patient was treated with LEXAPRO, NEXIUM, CLARINEX, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STRATTERA problem on Mar 20, 2007. Male patient, child 8 years of age, weighting 50.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: heart rate increased. STRATTERA dosage: 18MG 1 DAILY FOR 4 DAYS PO. Patient recovered.

STRATTERA problem was reported by a Physician from GERMANY on Mar 12, 2007. Male patient, child 12 years of age, weighting 114.4 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: depression, intentional self-injury, suicidal ideation. STRATTERA dosage: 25 MG, EACH MORNING. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 12, 2007. Male patient, child 10 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: chest pain, supraventricular tachycardia. STRATTERA dosage: 36 MG, DAILY (1/D). Patient recovered.

STRATTERA problem was reported by a Physician from UNITED KINGDOM on Mar 12, 2007. Male patient, 13 years of age, weighting 123.5 lb, was diagnosed with attention deficit/hyperactivity disorder, epilepsy and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: anaphylactoid reaction, confusional state, dizziness, feeling cold, hyperhidrosis, loss of consciousness, rash erythematous, somnolence, vertigo. STRATTERA dosage: 25 MG, UNK. During the same period patient was treated with TEGRETOL, RITALIN, CONCERTA. Patient recovered.

Physician from AUSTRIA reported STRATTERA problem on Mar 14, 2007. Female patient, 16 years of age, weighting 161.6 lb, was diagnosed with attention deficit/hyperactivity disorder, aggression and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: impulse-control disorder, restlessness, sleep disorder. STRATTERA dosage: 72 MG, DAILY (1/D). During the same period patient was treated with TRUXAL. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Pharmacist from UNITED STATES on Mar 27, 2007. Male patient, child 7 years of age, weighting 48.50 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: aggression, mania. STRATTERA dosage: 60 MG DAILY PO. Patient was hospitalized and became disabled. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 14, 2007. Male patient, child 10 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: accident, dysphagia, trismus. STRATTERA dosage: unknown. During the same period patient was treated with ZOLOFT, RISPERDAL. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED KINGDOM on Mar 14, 2007. Male patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: depression, psychomotor retardation, social avoidant behaviour, tearfulness. STRATTERA dosage: 70 MG, UNK. During the same period patient was treated with CANNABIS. Patient recovered.

Physician from CANADA reported STRATTERA problem on Mar 14, 2007. Male patient, child 9 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged. STRATTERA dosage: unknown. Patient recovered.

STRATTERA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Male patient, 13 years of age, was diagnosed with attention deficit/hyperactivity disorder, blood growth hormone and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: conduct disorder, convulsion, gaze palsy, tremor, unresponsive to stimuli. STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with HUMATROPE. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 16, 2007. Male patient, child 7 years of age, was diagnosed with attention deficit/hyperactivity disorder, sleep disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: aggression, convulsion, pyromania, snoring, somnolence. STRATTERA dosage: 2 MG/KG, UNK. During the same period patient was treated with ZOLOFT, RISPERDAL, MELATONIN. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 14 years of age, weighting 119.5 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: chest pain, dizziness, dyspnoea, electrocardiogram abnormal, epistaxis, loss of consciousness, panic attack, rhinitis allergic, scleritis. STRATTERA dosage: 60 MG, UNK. During the same period patient was treated with WELLBUTRIN. Patient recovered.

Health Professional from UNITED STATES reported STRATTERA problem on Mar 29, 2007. Male patient, 44 years of age, weighting 195.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, amnesia, insomnia, poor quality sleep, psychotic disorder. STRATTERA dosage: unknown. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 21 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: convulsion, loss of consciousness. STRATTERA dosage: unknown. During the same period patient was treated with AMNESTEEM. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 19, 2007. Male patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, chromaturia, fatigue, jaundice, liver function test abnormal, prescribed overdose. STRATTERA dosage: 60 MG, EACH MORNING. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Mar 20, 2007. Female patient, 25 years of age, was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: dizziness postural, syncope. STRATTERA dosage: unknown. Patient recovered.

Physician from AUSTRIA reported STRATTERA problem on Mar 20, 2007. Male patient, child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, rash. STRATTERA dosage: 18 MG, DAILY (1/D). Patient recovered.

STRATTERA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2007. Male patient, child 10 years of age, weighting 125.0 lb, was diagnosed with attention deficit/hyperactivity disorder, anxiety and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, head injury, loss of consciousness, post concussion syndrome. STRATTERA dosage: 40 MG, UNK. During the same period patient was treated with KLONOPIN. Patient recovered.

Physician from IRELAND reported STRATTERA problem on Mar 20, 2007. Male patient, 14 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, gastric ulcer. STRATTERA dosage: 25 MG, UNK. Patient recovered.

STRATTERA problem was reported by a Physician from UNITED STATES on Mar 20, 2007. Male patient, 22 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: haematemesis. STRATTERA dosage: 40 MG, UNK. During the same period patient was treated with NARCAN, NEURONTIN, RITALIN, ULTRAM. Patient recovered.

Physician from GERMANY reported STRATTERA problem on Mar 21, 2007. Male patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: migraine with aura. STRATTERA dosage: 18 MG, DAILY (1/D). During the same period patient was treated with MEDIKINET. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from GERMANY on Mar 23, 2007. Male patient, child 12 years of age, weighting 114.4 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: intentional self-injury, suicidal ideation. STRATTERA dosage: 25 MG, EACH MORNING. Patient recovered.

Physician from UNITED KINGDOM reported STRATTERA problem on Mar 22, 2007. Male patient, child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: apathy, chills, diarrhoea, feeling cold, headache, influenza like illness, insomnia, pain in extremity, pollakiuria. STRATTERA dosage: 40 MG, UNK. During the same period patient was treated with EQUASYM, RISPERIDONE. Patient recovered.

STRATTERA problem was reported by a Physician from GERMANY on Mar 22, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood bilirubin increased. STRATTERA dosage: 25 MG, 2/D. During the same period patient was treated with MEDIKINET. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 23, 2007. Male patient, child 7 years of age, weighting 44.09 lb, was diagnosed with attention deficit/hyperactivity disorder, sleep disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: aggression, convulsion, prescribed overdose, pyromania, snoring, somnolence. STRATTERA dosage: 2 MG/KG, DAILY (1/D). During the same period patient was treated with ZOLOFT, RISPERDAL, MELATONIN. Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from NETHERLANDS on Mar 26, 2007. Male patient, 13 years of age, weighting 78.71 lb, was diagnosed with attention deficit/hyperactivity disorder, sleep disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: arrhythmia, dyspnoea, exercise tolerance decreased, heart rate increased. STRATTERA dosage: 40 MG, UNK. During the same period patient was treated with MELATONIN. Patient recovered.

Physician from SWEDEN reported STRATTERA problem on Mar 26, 2007. Male patient, 14 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, loss of consciousness. STRATTERA dosage: 40 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.

STRATTERA problem was reported by a Physician from NORWAY on Mar 28, 2007. Male patient, 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, respiratory failure. STRATTERA dosage: unknown. During the same period patient was treated with RITALIN, ETHANOL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported STRATTERA problem on Mar 29, 2007. Male patient, 25 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gilbert's syndrome, haematuria, hepatocellular damage, hyperbilirubinaemia. STRATTERA dosage: unknown. Patient recovered.

Showing 1-75 of 657 Next >

Ask Our Patient Community about STRATTERA

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil

PatientsVille.com

Stay Healthy, Stay Informed

"The greatest wealth is health." - Virgil

Our Experts answered these questions:

Vaccine Safety

Menu

More Resources

STRATTERA Safety Questions, STRATTERA Answers

More Here>>Side Effects - FDA Reports 2006-2008

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about STRATTERA

Do You Have a Question about Your Health?

STRATTERA Safety Reports

Ask Our Patient Community about STRATTERA

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions